Biostar Pharmaceuticals, Inc. Total Liabilities and Equity
Biostar Pharmaceuticals, Inc. had Total Liabilities and Equity of $41.43 million as of 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2017-11-20
- 2017-09-30: Liabilities and Equity $41.43M.
- 2017-06-30: Liabilities and Equity $40.78M.
- 2017-03-31: Liabilities and Equity $41.49M.
- 2016-12-31: Liabilities and Equity $42.50M.
| Period end | Liabilities and Equity |
|---|---|
| 2017-09-30 | $41.43M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $40.78M 10-Q · filed 2017-11-15 |
| 2017-03-31 | $41.49M 10-Q · filed 2017-05-19 |
| 2016-12-31 | $42.50M 10-Q · filed 2017-11-20 |
| 2016-09-30 | $40.56M 10-Q · filed 2016-11-21 |
| 2016-06-30 | $42.06M 10-Q · filed 2016-08-22 |
| 2016-03-31 | $50.38M 10-Q · filed 2016-05-23 |
| 2015-12-31 | $51.36M 10-K · filed 2017-04-13 |
| 2015-09-30 | $78.47M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $81.95M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $80.79M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $81.25M 10-K · filed 2016-04-14 |
| 2014-09-30 | $78.98M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $77.24M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $72.43M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $67.56M 10-K · filed 2015-04-15 |
| 2013-09-30 | $72.38M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $71.19M 10-Q · filed 2013-08-19 |
| 2013-03-31 | $70.29M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $70.48M 10-K · filed 2014-03-31 |
| 2012-09-30 | $68.31M 10-Q · filed 2012-11-19 |
| 2012-06-30 | $72.11M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $85.36M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $83.06M 10-K · filed 2013-04-15 |
| 2011-09-30 | $86.50M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $79.77M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $68.09M 10-K · filed 2012-03-27 |